Drug rash with eosinophilia and systemic symptoms syndrome
Revision as of 11:41, 4 May 2016 by Neil.m.young (talk | contribs) (sources removed because they do not relate to specific facts; added to external links)
Background
- Known as "DRESS" syndrome
- A severe adverse drug reaction
- Usually begins within 8 weeks of starting a new drug
- 8-10% mortality
- Previously known as Dilantin Hypersensitivity Syndrome or anti-convulsant hypersensitivity syndrome[1]
- However, many other medications, particularly antibiotics
Associated Drugs
- Most common
- phenytoin
- phenobarbital
- carbamezapine
- allopurinol
- sulfa drugs
- Others
- NSAIDS
- anti-retrovirals
- ACE-I
- CCBs
- other antibiotics
Clinical Features
- Fever and rash (varying; may resemble SJS) are typically first signs
- +/- lymphadenopathy
- liver, kidney or hematologic system involvement
- atypical lymphocytes, thrombocytopenia
- Despite name, eosinophilia only in ~30% of cases
Differential Diagnosis
- SJS/TENS
- Kawasaki Disease
- TTP
- See Rashes
Workup
- CBC with diff
- BMP
- Biopsy (as inpt)
Management
- Discontinue suspected drug
- Supportive care: anti-pyretic, anti-puritic
- Systemic steroids in severe cases (controversial)
- hepatitis, pneumonitis, extensive exfoliative dermatitis
- Family counseling as possible genetic component
Disposition
Admit
See Also
External Links
References
- ↑ Herbert M. EM:RAP Board Review Answers: February 2015. February 2015: Volume 15, Issue 2. www.emrap.org.
